No, the current GLP-1 litigation is not proceeding as a traditional class action lawsuit
Or why isn't it on the other side dropping my basal metabolic rate so now I'm still gaining weight, or I'm staying at a sort of consistent level even at this lower calorie intake that the GLP-1 is allowing for me to have
F.DokrasA.LavenJ.MoranL.et al (2018)
It is one molecule packaged under two brand names, each with its own FDA approval, its own insurance classification, and its own coverage pathway
First, the participants in this study were exclusively Japanese, which might limit the generalizability of the findings to other populations
The higher health care costs associated with taking GLP-1 RAs were largely attributable to high drug costs, of which over 95% were covered by insurance